// App-Quantinova.ai

TCT CONNECT-301 : Incidence, Predictors, and Impact of Readmissions Following PCI and CABG for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial

Researchers

Presenter

  • Ioanna Kosmidou

Principal Investigators

  • Bahira Shahim

  • Zixuan Zhang

  • Ovidiu Dressler

  • Bjorn Redfors

  • Marie-Claude Morice

  • David Kandzari

  • Dimitri Karmpaliotis

  • William Brown

  • Nicholas Lembo

  • Adrian Banning

  • Patrick Serruys

  • Gregg Stone

Medical Centers

  • Medicine, National University of Ireland Galway, Galway, IRELAND

  • Mount Sinai Heart Health System, New York, New York, USA

  • Institut Cardiovasculaire Paris Sud, Massy, France

  • Columbia University Medical Center, New York, NY

  • Piedmont Heart Institute CardioThoracic Surgeons, Atlanta, Georgia

  • John Radcliffe Hospital, Oxford, United Kingdom.

  • CARDIOVASCULAR RESEARCH FOUNDATION, New York, NY

  • Piedmont Heart Institute, Atlanta, GA

Locations

  • Ireland

  • United States

  • Georgia

  • France

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Left main disease

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved